van den Bergh Joop, van Geel Tineke, Geusens Piet
Universitair Medisch Centrum Maastricht, Afd. Interne Geneeskunde, subdivisie Endocrinologie, Maastricht, The Netherlands.
Ned Tijdschr Geneeskd. 2010;154:A1758.
Vitamin D deficiency is endemic worldwide. The Health Council of the Netherlands advises a colecalciferol intake of 800 IU/day and an intended serum level of calcidiol of at least 50 nmol/l for people aged 50 years and older and for osteoporosis patients. In 64% of 626 fracture patients, we found a reduced serum calcidiol level according to this definition. According to calculations based on meta-analyses, a substantial proportion of fracture patients would not achieve the target calcidiol level of 50 nmol/l with a vitamin D supplement of 800 IU/day. For example, this would be the case in 37% of elderly patients with osteoporosis. Until the results of a prospective study on this are published, we propose that fracture patients are either systematically given doses of vitamin D supplements higher than 800 IU/day, or that their serum calcidiol is measured and the dose of vitamin D supplements is adjusted according to this initial value and the desired serum concentrations, and that the measurement is repeated after 3 months so that the dosage can be adjusted if necessary.
维生素D缺乏在全球范围内普遍存在。荷兰健康委员会建议,50岁及以上人群和骨质疏松症患者的胆钙化醇摄入量为每日800国际单位,血清骨化二醇水平目标至少为50纳摩尔/升。在626名骨折患者中,根据这一定义,我们发现64%的患者血清骨化二醇水平降低。根据荟萃分析的计算结果,相当一部分骨折患者每日补充800国际单位维生素D无法达到50纳摩尔/升的骨化二醇目标水平。例如,37%的老年骨质疏松症患者就是这种情况。在关于此问题的前瞻性研究结果发表之前,我们建议,要么系统地给予骨折患者高于800国际单位/天的维生素D补充剂剂量,要么测量他们的血清骨化二醇,并根据初始值和期望的血清浓度调整维生素D补充剂剂量,且在3个月后重复测量,以便必要时调整剂量。